Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure

Can J Physiol Pharmacol. 2023 Sep 25. doi: 10.1139/cjpp-2023-0226. Online ahead of print.ABSTRACTAngiotensin (Ang II ) is formed by the action of angiotensin converting enzyme (ACE) in the renin- angiotensin system. This hormone is known to induce cardiac hypertrophy and heart failure and its actions are mediated by the interaction of both pro- and anti- hypertrophic Ang II receptors ( AT1R and AT2R). Ang II is also metabolized by ACE 2 to Ang 1-7, which elicits the activation of Mas receptors ( MasR) for inducing antihypertrophic actions. Since heart failure under different pathophysiological situations is preceded by adaptive and maladaptive cardiac hypertrophy, we have reviewed the existing literature to gain some information regarding the roles of AT1R, AT2R and MasR in both acute and chronic conditions of cardiac hypertrophy. It appears that the activation of AT1R may be involved in the development of adaptive and maladaptive cardiac hypertrophy as well as subsequent heart failure because both ACE inhibitors and AT1R antagonists exert beneficial effects. On the other hand, the activation of both AT2R and MasR may prevent the occurrence of maladaptive cardiac hypertrophy and delay the progression of heart failure and thus therapy with different activators of these antihypertrophic receptors under chronic pathological stages may prove beneficial. Accordingly, it is suggested that a great deal of effort should be made to develop appropriate activators of both AT2R and MasR ...
Source: Canadian Journal of Physiology and Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research